Cash position suggests another cap raise in the next couple of quarters.Margins are slim, research report used a 10% DCF.Highly speculative at best.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025